Sarah McGlasson

ORCID: 0000-0002-0077-0991
Publications
Citations
Views
---
Saved
---
About
Contact & Profiles
Research Areas
  • Systemic Lupus Erythematosus Research
  • interferon and immune responses
  • Immune Response and Inflammation
  • Antimicrobial Peptides and Activities
  • Cytokine Signaling Pathways and Interactions
  • Peripheral Neuropathies and Disorders
  • Immunotherapy and Immune Responses
  • Multiple Sclerosis Research Studies
  • Atherosclerosis and Cardiovascular Diseases
  • Viral Infections and Immunology Research
  • Complement system in diseases
  • Neutrophil, Myeloperoxidase and Oxidative Mechanisms
  • Skin and Cellular Biology Research
  • Renal Diseases and Glomerulopathies
  • DNA Repair Mechanisms
  • Immune Cell Function and Interaction
  • RNA regulation and disease
  • Protein Tyrosine Phosphatases
  • Ubiquitin and proteasome pathways
  • Neuroinflammation and Neurodegeneration Mechanisms
  • Polyomavirus and related diseases
  • Inflammasome and immune disorders
  • Immune responses and vaccinations
  • T-cell and B-cell Immunology
  • Mitochondrial Function and Pathology

University of Edinburgh
2015-2024

UK Dementia Research Institute
2018-2024

Institute of Genetics and Cancer
2015-2019

Medical Research Council
2016-2019

University of Cambridge
2017

University of Lincoln
2017

Type I interferons (IFNs) are essential mediators of antiviral responses. These cytokines have been implicated in the pathogenesis autoimmunity, most notably systemic lupus erythematosus (SLE), diabetes mellitus, and dermatomyositis, as well monogenic type interferonopathies. Despite a fundamental role health disease, direct quantification IFNs has challenging. Using single-molecule array (Simoa) digital ELISA technology, we recorded attomolar concentrations IFNα healthy donors, viral...

10.1084/jem.20161451 article EN cc-by-nc-sa The Journal of Experimental Medicine 2017-04-18

Human β-defensin 3 (hBD3) is a cationic antimicrobial peptide with potent bactericidal activity in vitro. HBD3 produced response to pathogen challenge and can modulate immune responses. The amplified recognition of self-DNA by human plasmacytoid dendritic cells has been previously reported, but we show here that hBD3 preferentially enhances the bacterial DNA mouse Flt-3 induced (FLDCs) peripheral blood mononuclear cells. We effect mediated through TLR9 although significantly increases...

10.1002/eji.201646799 article EN cc-by European Journal of Immunology 2017-01-19

Human β-defensin 3 (hBD3) is a cationic host defence peptide and part of the innate immune response. HBD3 present on highly copy number variable block six genes, increased associated with autoimmune disease psoriasis. It not known how this increase influences development, but psoriasis T cell-mediated activation system required for initial trigger that leads to amplification stage. We investigated effect hBD3 response primary macrophages various TLR agonists. exacerbated production type I...

10.1371/journal.pgen.1005673 article EN cc-by PLoS Genetics 2015-12-08

<ns4:p><ns4:bold>Background:</ns4:bold> Monoallelic and biallelic mutations in the exonuclease <ns4:italic>TREX1</ns4:italic> cause monogenic small vessel diseases (SVD). Given recent evidence for genetic pathophysiological overlap between polygenic forms of SVD, evaluation stroke is warranted.</ns4:p><ns4:p> <ns4:bold>Methods:</ns4:bold> We sequenced gene an exploratory cohort patients with lacunar (Edinburgh Stroke Study, n=290 cases). subsequently performed a fully blinded case-control...

10.12688/wellcomeopenres.12631.1 preprint EN cc-by Wellcome Open Research 2017-11-02

ABSTRACT Introduction Type I interferons are cytokines involved in innate immunity against viruses. Genetic disorders of type interferon regulation associated with a range autoimmune and cerebrovascular phenotypes. Carriers pathogenic variants genetic generally considered asymptomatic. Preliminary data suggests, however, that genetically determined dysregulation responses is autoimmunity, may also be relevant to sporadic disease dementia. We aim determine whether functional genes signalling...

10.1101/2023.10.12.23296935 preprint EN cc-by medRxiv (Cold Spring Harbor Laboratory) 2023-10-13

Type I interferons are cytokines involved in innate immunity against viruses. Genetic disorders of type interferon regulation associated with a range autoimmune and cerebrovascular phenotypes. Carriers pathogenic variants genetic generally considered asymptomatic. Preliminary data suggests, however, that genetically determined dysregulation responses is autoimmunity, may also be relevant to sporadic disease dementia. We aim determine whether functional genes signalling the risk stroke,...

10.12688/wellcomeopenres.20385.1 preprint EN cc-by Wellcome Open Research 2023-11-23
Coming Soon ...